Table 1 Baseline clinical and radiological characteristics of patients after randomisation in A. paniculata and placebo treatment groups
Parameter | A. paniculata n = 13 | Placebo n = 11 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | min | max | Mean | SD | min | max | p-value | |||
Age | 35.09 | 11.79 | 15 | 47 | 38.70 | 10.65 | 22 | 51 | 0.3066 | ||
Sex (w/m) | 9/4 | 7/4 | 0.5250 | ||||||||
Disease duration prior to study (year) | 3.62 | 4.56 | 0 | 16 | 6.00 | 8.20 | 0 | 24 | 0.8067 | ||
Relapse (2 years) | 1.73 | 1.27 | 1 | 5 | 1.46 | 0.52 | 1 | 2 | 0.9236 | ||
EDSS | 2.64 | 1.29 | 1 | 5 | 2.08 | 1.66 | 0 | 6 | 0.1663 | ||
FSS | 4,15 | 1,88 | 1 | 6.4 | 3.76 | 1.68 | 1 | 5.5 | 0.3990 | ||
Gd lesion number | 0 | 0 | |||||||||
Interferon-beta 1a im.(Avonex® 30 mcg) | 7 | 5 | |||||||||
Interferon-beta 1a sc.(Rebif® 44 mcg) | 6 | 6 | |||||||||